Vincent Bond to Breast Neoplasms
This is a "connection" page, showing publications Vincent Bond has written about Breast Neoplasms.
Connection Strength
0.714
-
Huang MB, Brena D, Wu JY, Roth WW, Owusu S, Bond VC. Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells. Sci Rep. 2022 08 01; 12(1):13204.
Score: 0.388
-
Huang MB, Gonzalez RR, Lillard J, Bond VC. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells. Oncotarget. 2017 Feb 14; 8(7):11302-11315.
Score: 0.266
-
Katkoori VR, Basson MD, Bond VC, Manne U, Bumpers HL. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers. Oncotarget. 2015 Sep 29; 6(29):27763-77.
Score: 0.060